Peter Smibert
Auto-generated profile, based on publicly available information

Peter Smibert

New York Genome Center, New York, USA

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2021 in Cell
Verified
Journal Article
Open access
YHYuhan Hao
Yuhan Hao
SHStephanie Hao
Stephanie Hao
EAErica Andersen-Nissen
Erica Andersen-Nissen
WMWilliam M. Mauck
William M. Mauck
SZShiwei Zheng
Shiwei Zheng
RSRahul Satija
Rahul Satija
The simultaneous measurement of multiple modalities represents an exciting frontier for single-cell genomics and necessitates computational methods that can define cellular states based on multimodal data. Here, we introduce "weighted-nearest neighbor" analysis, an unsupervised framework to learn the relative utility of each data type in each cell, enabling an integrative analysis of multiple modalities. We apply our procedure to a CITE-seq dataset of 211,000 human peripheral blood mononuclear cells (PBMCs) with panels extending to 228 antibodies to construct a multimodal reference atlas of the circulating immune system. Multimodal analysis substantially improves our ability to resolve cell states, allowing us to identify and validate previously unreported lymphoid subpopulations. Moreover, we demonstrate how to leverage this reference to rapidly map new datasets and to interpret immune responses to vaccination and coronavirus disease 2019 (COVID-19). Our approach represents a broadly applicable strategy to analyze single-cell multimodal datasets and to look beyond the transcriptome toward a unified and multimodal definition of cellular identity.

1 June 2019 in Cell
Verified
Journal Article
Closed access
TSTim Stuart
Tim Stuart
ABAndrew Butler
Andrew Butler
PHPaul Hoffman
Paul Hoffman
CHChristoph Hafemeister
Christoph Hafemeister
EPEfthymia Papalexi
Efthymia Papalexi
RSRahul Satija
Rahul Satija

31 July 2017 in Nature Methods
Verified
Journal Article
Open access
PDF file
MSMarlon Stoeckius
Marlon Stoeckius
CHChristoph Hafemeister
Christoph Hafemeister
WSWilliam Stephenson
William Stephenson
BHBrian Houck-Loomis
Brian Houck-Loomis
PCPratip K Chattopadhyay
Pratip K Chattopadhyay
PSPeter Smibert
Peter Smibert
Using established high-throughput single-cell RNA-seq platforms, CITE-seq combines highly multiplexed, antibody-based protein marker quantification with unbiased transcriptome profiling for thousands of single cells. High-throughput single-cell RNA sequencing has transformed our understanding of complex cell populations, but it does not provide phenotypic information such as cell-surface protein levels. Here, we describe cellular indexing of transcriptomes and epitopes by sequencing (CITE-seq), a method in which oligonucleotide-labeled antibodies are used to integrate cellular protein and transcriptome measurements into an efficient, single-cell readout. CITE-seq is compatible with existing single-cell sequencing approaches and scales readily with throughput increases.

19 December 2018 in Genome Biology
Verified
Journal Article
Open access
PDF file
MSMarlon Stoeckius
Marlon Stoeckius
SZShiwei Zheng
Shiwei Zheng
BHBrian Houck-Loomis
Brian Houck-Loomis
SHStephanie Hao
Stephanie Hao
BYBertrand Z. Yeung
Bertrand Z. Yeung
RSRahul Satija
Rahul Satija
Despite rapid developments in single cell sequencing, sample-specific batch effects, detection of cell multiplets, and experimental costs remain outstanding challenges. Here, we introduce Cell Hashing, where oligo-tagged antibodies against ubiquitously expressed surface proteins uniquely label cells from distinct samples, which can be subsequently pooled. By sequencing these tags alongside the cellular transcriptome, we can assign each cell to its original sample, robustly identify cross-sample multiplets, and “super-load” commercial droplet-based systems for significant cost reduction. We validate our approach using a complementary genetic approach and demonstrate how hashing can generalize the benefits of single cell multiplexing to diverse samples and experimental designs.

16 May 2011 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
Alberto DavalosAlberto Davalos
Alberto Davalos
LGLeigh Goedeke
Leigh Goedeke
PSPeter Smibert
Peter Smibert
Cristina M. Ramírez HidalgoCristina M. Ramírez Hidalgo
Cristina M. Ramírez Hidalgo
NWNikhil P. Warrier
Nikhil P. Warrier
CFCarlos Fernández-Hernando
Carlos Fernández-Hernando
Cellular imbalances of cholesterol and fatty acid metabolism result in pathological processes, including atherosclerosis and metabolic syndrome. Recent work from our group and others has shown that the intronic microRNAs hsa-miR-33a and hsa-miR-33b are located within the sterol regulatory element-binding protein-2 and -1 genes, respectively, and regulate cholesterol homeostasis in concert with their host genes. Here, we show that miR-33a and -b also regulate genes involved in fatty acid metabolism and insulin signaling. miR-33a and -b target key enzymes involved in the regulation of fatty acid oxidation, including carnitine O -octaniltransferase, carnitine palmitoyltransferase 1A, hydroxyacyl-CoA-dehydrogenase, Sirtuin 6 (SIRT6), and AMP kinase subunit-α. Moreover, miR-33a and -b also target the insulin receptor substrate 2, an essential component of the insulin-signaling pathway in the liver. Overexpression of miR-33a and -b reduces both fatty acid oxidation and insulin signaling in hepatic cell lines, whereas inhibition of endogenous miR-33a and -b increases these two metabolic pathways. Together, these data establish that miR-33a and -b regulate pathways controlling three of the risk factors of metabolic syndrome, namely levels of HDL, triglycerides, and insulin signaling, and suggest that inhibitors of miR-33a and -b may be useful in the treatment of this growing health concern.

3 June 2021 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
EMEleni P. Mimitou
Eleni P. Mimitou
CLCaleb A. Lareau
Caleb A. Lareau
KCKelvin Y. Chen
Kelvin Y. Chen
AZAndre L. Zorzetto-Fernandes
Andre L. Zorzetto-Fernandes
YHYuhan Hao
Yuhan Hao
PSPeter Smibert
Peter Smibert